These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
79 related items for PubMed ID: 4464986
1. [Immunotherapy of experimental colonic cancer: immunologic enhancement of grafted tumor]. Martin MS, Martin F, Lagneau A, Horiot JC, Chomono R. Biol Gastroenterol (Paris); 1974; 7(4):249-52. PubMed ID: 4464986 [No Abstract] [Full Text] [Related]
2. Effects of specific active immunization on tumor recurrence following primary tumor resection in WF rats with 1,2-dimethylhydrazine-induced bowel cancer. Ross DS, Steele G, Madara J, Lahey SJ, Ravikumar TS, Wilson RE, Munroe AE, Wright D, King VP. J Natl Cancer Inst; 1984 Sep; 73(3):731-5. PubMed ID: 6590917 [Abstract] [Full Text] [Related]
3. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma. Lumsden AJ, Codde JP, Van der Meide PH, Gray BN. Anticancer Res; 1996 Sep; 16(3A):1145-54. PubMed ID: 8702226 [Abstract] [Full Text] [Related]
4. Immunoprophylaxis and therapy of grafted rat colonic carcinoma. Martin MS, Martin F, Justrabo E, Michel MF, Lagneau A. Gut; 1977 Mar; 18(3):232-5. PubMed ID: 323119 [Abstract] [Full Text] [Related]
5. Specific active immunotherapy with butanol-extracted, tumor-associated antigens incorporated into liposomes. Steele G, Ravikumar T, Ross D, King V, Wilson RE, Dodson T. Surgery; 1984 Aug; 96(2):352-9. PubMed ID: 6463864 [Abstract] [Full Text] [Related]
7. [A model for colon cancer immunology and immunotherapy: the PRO/REG cell variants]. Martin F, Martin M. Gastroenterol Clin Biol; 2000 Oct; 24(10):923-8. PubMed ID: 11084430 [No Abstract] [Full Text] [Related]
12. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer. Simmons RL, Rios A. Johns Hopkins Med J Suppl; 1974 May; 3():75-84. PubMed ID: 4536589 [No Abstract] [Full Text] [Related]
13. The effect of "tissue-type" specific immunotherapy on colon cancer recurrence in a minimal residual disease model. Harte PJ, Steele G, Rayner AA, Corson JM, Munroe AE, King VP, Wilson RE. Curr Surg; 1982 May; 39(1):21-3. PubMed ID: 7060396 [No Abstract] [Full Text] [Related]